Type-1 Diabetes

<p>3D optical molecular imaging of the rodent pancreas by OPT and LSFM.-&nbsp;Uncommon Transplantation Sites – Transplantation of islets and islet organoids in the anterior chamber of the eye of rodents and monkeys.-&nbsp;Generation of Insulin-producing multicellular organoids.-&nbsp;Non-invasive quantitative PET Imaging in humans of the Pancreatic Beta Cell Mass biomarkers VMAT2 and Dopamine, D2/D3 receptors, in vivo.-&nbsp;In Vivo Imaging of Naked and Microencapsulated&nbsp;Islet Cell Transplantation.-&nbsp;Diabetes retinopathy: new ways to detect and treat.-&nbsp;MRI methods for imaging beta-cell function in the rodent pancreas.-&nbsp;MicroRNAs in type 2 diabetes – focus on microRNA profiling in Islets of Langerhans.-&nbsp;Protocol for clinical GLP-1 receptor PET/CT imaging with [⁶⁸Ga]Ga-NODAGA-exendin-4.-&nbsp;Hyperinsulinemic-euglycemic clamp in conscious rats based on the tail artery and vein catheterization.-&nbsp;Synthesis of siRNA-conjugated dextran-coated iron oxide nanoparticles for islet protection during transplantation and noninvasive imaging.-&nbsp;Micelle-Based Nanocarriers for Targeted Delivery of Cargo to Pancreas.-&nbsp;Magnetic particle imaging of transplanted human islets using a machine learning algorithm.-&nbsp;In vivo bioluminescence for the detection of the fate of pancreatic islet organoids post-transplantation.-&nbsp;miRNA theranostic nanoparticles promote pancreatic beta cell proliferation in type 1 diabetes model.-&nbsp;Isolation and purification of human pancreatic islets.-&nbsp;Vascularized islet transplantation as composite Islet-Kidney grafts with nanoparticle-labeled islets in large animal preclinical transplant models.&nbsp;</p>

<p>&nbsp;<br></p>

<p>&nbsp;</p>